PBT434 Prevents Neuron Loss, Improves Motor Function in Animal Model of Neurodegeneration, Prana Reports
Prana Biotechnology’s investigational compound PBT434 prevented neuronal loss and improved motor function in an animal model of multiple system atrophy (MSA), a condition that shares many of Parkinson’s motor symptoms, according to preclinical data. MSA is a progressive disorder affecting both involuntary functions, such as blood pressure,…